Info

M&A Science

M&A Science is a podcast exploring the intricate world of mergers and acquisitions with industry leaders and practitioners. With an unlimited access to our deal network, these interviews examine M&A trends, culture, and best practices. This podcast is sponsored by DealRoom, an M&A lifecycle management platform.
RSS Feed Subscribe in Apple Podcasts
M&A Science
2024
April
March
February
January


2023
December
November
October
September
August
July
June
May
April
March
February
January


2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April


2018
July
June
May
February


2017
December
September
March
February


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Jun 12, 2023

Mark Legaspi, Director, Legal - Corporate at LinkedIn

Hello M&A Friends, if you're looking to improve your in-house training, we have corporate training plans provided through M&A Science Academy.

Give your team members access to the best in class courses, templates, and networking opportunities in the industry. Our academy was designed to lead practitioners with the outdo with the M&A practices.

If you're interested in learning more about individual or team plans, go to www.mascience.com/academy. It's also a great way to show your support for M&A Science. Again, that's mascience.com/academy.

Episode Timestamps

00:00 Intro

02:53 Key Considerations for M&A in 2023

05:22 Regulatory Challenges

09:41 Effect of Regulatory on Negotiations

15:43 Managing Value

17:51 Other Considerations Regarding Regulatory Risks

20:38 Suing the Regulatory Bodies

32:18 Regulatory Effects on Employees

34:08 Other Deal Killers in M&A

38:04 Trademarks Killing Deals

40:30 Market situation with IPs

42:22 Deal Breaks Due to IP

43:48 Advice for Deal Teams

46:39 Craziest thing in M&A

 

0 Comments
Adding comments is not available at this time.